Detalhe da pesquisa
1.
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Oncologist
; 29(4): 303-310, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37995313
2.
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Cancer Immunol Immunother
; 72(10): 3217-3228, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37428196
3.
Dynamic Changes of Peripheral NK Cells Predict Outcome in Patients with PD-L1 Positive Non-small-cell Lung Cancer Undergoing Immune Checkpoint Inhibitors as Second-line Therapy.
Cancer Invest
; 40(8): 710-721, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35736808
4.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34875670
5.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31943171
6.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30536609
7.
Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade.
Cancers (Basel)
; 16(2)2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38275894
8.
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.
Clin Exp Med
; 24(1): 13, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38244147
9.
Effects of Acetaminophen Exposure on Outcomes of Patients Receiving Immune Checkpoint Inhibitors for Advanced Non-Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
Curr Oncol
; 30(9): 8117-8133, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37754504
10.
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.
Front Oncol
; 13: 1280416, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38023235
11.
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
Curr Oncol
; 30(5): 5103-5115, 2023 05 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37232844
12.
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study.
Cancers (Basel)
; 15(14)2023 Jul 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37509286
13.
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Front Oncol
; 13: 1177681, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37441419
14.
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature.
Front Oncol
; 12: 797157, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35223478
15.
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study.
Int Immunopharmacol
; 108: 108774, 2022 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-35461110
16.
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Sci Rep
; 12(1): 21908, 2022 12 19.
Artigo
Inglês
| MEDLINE | ID: mdl-36535985
17.
Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis.
Cureus
; 14(10): e30607, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36299600
18.
CDK4/6 Inhibitor Treatments in Patients with Hormone Receptor Positive, Her2 Negative Advanced Breast Cancer: Potential Molecular Mechanisms, Clinical Implications and Future Perspectives.
Cancers (Basel)
; 13(2)2021 Jan 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33477469
19.
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET).
Clin Cancer Res
; 27(12): 3443-3455, 2021 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33785482
20.
Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials.
Cancers (Basel)
; 12(9)2020 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32899209